Stay updated with breaking news from Event Lowering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.
People with diabetic retinopathy who took the cholesterol-lowering drug fenofibrate were less likely to progress to vision-threatening forms of the disease, in a large database study.